Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 9;13(2):362.
doi: 10.3390/jcm13020362.

A Comprehensive Review of Risk Factors and Thrombophilia Evaluation in Venous Thromboembolism

Affiliations
Review

A Comprehensive Review of Risk Factors and Thrombophilia Evaluation in Venous Thromboembolism

Andrew B Dicks et al. J Clin Med. .

Abstract

Venous thromboembolism (VTE), which encompasses deep vein thrombosis (DVT) and pulmonary embolism (PE), is a significant cause of morbidity and mortality worldwide. There are many factors, both acquired and inherited, known to increase the risk of VTE. Most of these result in increased risk via several common mechanisms including circulatory stasis, endothelial damage, or increased hypercoagulability. Overall, a risk factor can be identified in the majority of patients with VTE; however, not all risk factors carry the same predictive value. It is important for clinicians to understand the potency of each individual risk factor when managing patients who have a VTE or are at risk of developing VTE. With this, many providers consider performing a thrombophilia evaluation to further define a patient's risk. However, guidance on who to test and when to test is controversial and not always clear. This comprehensive review attempts to address these aspects/concerns by providing an overview of the multifaceted risk factors associated with VTE as well as examining the role of performing a thrombophilia evaluation, including the indications and timing of performing such an evaluation.

Keywords: deep vein thrombosis; pulmonary embolism; risk factors; thrombophilia; venous thromboembolism.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Pastori D., Cormaci V.M., Marucci S., Franchino G., Del Sole F., Capozza A., Fallarino A., Corso C., Valeriani E., Menichelli D., et al. A Comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology. Int. J. Mol. Sci. 2023;24:3169. doi: 10.3390/ijms24043169. - DOI - PMC - PubMed
    1. Anderson F.A., Spencer F.A. Risk factors for venous thromboembolism. Circulation. 2003;107((Suppl. S1)):I9–I16. doi: 10.1161/01.CIR.0000078469.07362.E6. - DOI - PubMed
    1. Konstantinides S.V., Meyer G., Becattini C., Bueno H., Geersing G.-J., Harjola V.-P., Huisman M.V., Humbert M., Jennings C.S., Jiménez D., et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) Eur. Heart J. 2020;41:543–603. doi: 10.1093/eurheartj/ehz405. - DOI - PubMed
    1. Prandoni P., Lensing A.W., Cogo A., Cuppini S., Villalta S., Carta M., Cattelan A.M., Polistena P., Bernardi E., Prins M.H. The long-term clinical course of acute deep venous thrombosis. Ann. Intern. Med. 1996;125:1–7. doi: 10.7326/0003-4819-125-1-199607010-00001. - DOI - PubMed
    1. Anderson F.A., Wheeler H.B. Physician practices in the management of venous thromboembolism: A community-wide survey. J. Vasc. Surg. 1992;16:707–714. doi: 10.1016/0741-5214(92)90225-W. - DOI - PubMed

LinkOut - more resources